R. Cojocneanu

发表

MicroRNA profiling in kidney in pigs fed ochratoxin A contaminated diet.

C. Braicu, D. Marin, I. Țăranu, 2019, Ecotoxicology and environmental safety.

Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients

I. Berindan‐Neagoe, Lorand Magdo, S. Buduru, 2018, International journal of environmental research and public health.

Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines

Lavinia L. Pruteanu, E. Gurzău, I. Berindan‐Neagoe, 2022, International journal of molecular sciences.

Inhibitory Effect of CAPE and Kaempferol in Colon Cancer Cell Lines—Possible Implications in New Therapeutic Strategies

I. Berindan‐Neagoe, A. Atanasov, A. Irimie, 2019, International journal of molecular sciences.

New Insights in Gene Expression Alteration as Effect of Paclitaxel Drug Resistance in Triple Negative Breast Cancer Cells.

I. Berindan‐Neagoe, A. Irimie, C. Braicu, 2020, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

Circulating microRNA-194 and microRNA-1228 Could Predict Colon Cancer Proliferation via Phospho S6 Modulation.

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2020, Journal of gastrointestinal and liver diseases : JGLD.

The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-Analysis

M. Ferracin, I. Berindan‐Neagoe, S. Pintea, 2020, Frontiers in Oncology.

miR‐181a/b therapy in lung cancer: reality or myth?

G. Calin, I. Berindan‐Neagoe, Erik Knutsen, 2019, Molecular oncology.

Role of Key Micronutrients from Nutrigenetic and Nutrigenomic Perspectives in Cancer Prevention

I. Berindan‐Neagoe, Lorand Magdo, S. Pașca, 2019, Medicina.

The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer “Omics”

Ioana Berindan-Neagoe, Diana Gulei, Lavinia L. Pruteanu, 2019, International journal of molecular sciences.

Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer

I. Berindan‐Neagoe, A. Irimie, C. Braicu, 2019, Medicina.

Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2019, Journal of experimental & clinical cancer research : CR.

Aberrant miRNAs expressed in HER-2 negative breast cancers patient

A. Paradiso, I. Berindan‐Neagoe, A. Irimie, 2018, Journal of experimental & clinical cancer research : CR.

Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2020, Cancers.

Cancer-Associated Stemness and Epithelial-to-Mesenchymal Transition Signatures Related to Breast Invasive Carcinoma Prognostic

I. Berindan‐Neagoe, S. Korban, A. Irimie, 2020, Cancers.

Human Chorionic Gonadotropin Improves the Proliferation and Regenerative Potential of Bone Marrow Adherent Stem Cells and the Immune Tolerance of Fetal Microchimeric Stem Cells In Vitro

C. Braicu, O. Sorițău, C. Moldovan, 2020, Stem Cell Reviews and Reports.

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

I. Berindan‐Neagoe, Alina-Andreea Zimta, A. Irimie, 2020, Journal of experimental & clinical cancer research : CR.

Alteration of Gene and miRNA Expression in Cervical Intraepithelial Neoplasia and Cervical Cancer

I. Berindan‐Neagoe, C. Braicu, L. Pop, 2022, International journal of molecular sciences.

MicroRNA Dysregulation in Prostate Cancer

I. Berindan‐Neagoe, C. Braicu, I. Coman, 2022, Pharmacogenomics and personalized medicine.

Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer

I. Berindan‐Neagoe, C. Braicu, P. Achimas-Cadariu, 2021, Diagnostics.

New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin

I. Berindan‐Neagoe, S. Korban, C. Braicu, 2020, Molecular and Cellular Biochemistry.

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

I. Berindan‐Neagoe, Alina-Andreea Zimta, A. Irimie, 2020, Journal of Experimental & Clinical Cancer Research.

Identification of Core Genes Involved in the Progression of Cervical Cancer Using an Integrative mRNA Analysis

I. Berindan‐Neagoe, S. Korban, A. Irimie, 2020, International journal of molecular sciences.

The shifting landscape of genetic alterations separating endometriosis and ovarian endometrioid carcinoma.

I. Berindan‐Neagoe, A. Irimie, H. Roman, 2021, American journal of cancer research.

Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression

I. Berindan‐Neagoe, A. Irimie, Lorand Magdo, 2019, Journal of Experimental & Clinical Cancer Research.

New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin

I. Berindan‐Neagoe, S. Korban, C. Braicu, 2020, Molecular and Cellular Biochemistry.

Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC)

I. Berindan‐Neagoe, S. Pintea, O. Slabý, 2019, Journal of clinical medicine.

Human Chorionic Gonadotropin Improves the Proliferation and Regenerative Potential of Bone Marrow Adherent Stem Cells and the Immune Tolerance of Fetal Microchimeric Stem Cells In Vitro

C. Braicu, O. Sorițău, C. Moldovan, 2020, Stem Cell Reviews and Reports.

Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers

D. Dumitrascu, P. Monroig, Oana Zanoaga, 2015 .

Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers

D. Dumitrascu, P. Monroig, Oana Zanoaga, 2015 .

Aberrant miRNAs expressed in HER-2 negative breast cancers patient

A. Paradiso, I. Berindan‐Neagoe, A. Irimie, 2018, Journal of Experimental & Clinical Cancer Research.